Related Experiment Video
Updated: Apr 15, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Correlation between age and MMSE in schizophrenia
Jean-Robert Maltais1, Geneviève Gagnon2, Marie-Pierre Garant3
1Centre de Santé et de Services Sociaux,Institut Universitaire de Gériatrie de Sherbrooke,University of Sherbrooke,Quebec,Canada.
Background:
The Mini-Mental State Examination (MMSE) is widely used in schizophrenia, although normative data are lacking in this population. This review and meta-regression analysis studies the effect of aging on MMSE scores in schizophrenic patients.
Methods:
We entered the search terms schizophrenia and MMSE in PubMed and PsychInfo. Bibliographies of pertinent articles were also examined. We included every study presenting the MMSE scores in schizophrenic patients along with a corresponding mean age. We conducted our analyses using simple linear regression weighted for the inverse of within-trial variance of the age variable, thus conferring more importance to studies with narrower age groups.
Results:
We identified 56 articles (n = 5,588) published between 1990 and 2012. The MMSE scores of schizophrenic patients decline by approximately 1 point for every four years (y = 34.939-0.247x, 95% Confidence Interval (CI) [-0.304, -0.189], R 2 = 0,545), which is five times the rate in the general population. Institutionalized patients account for a large proportion of this decline (y = 37.603-0.308x, 95% CI [-0.349, -0.267], R 2 = 0.622) whereas community-dwelling patients are relatively stable throughout aging (y = 27.591-0.026x, 95% CI [-0.074, 0.023], R 2 = 0.037).
Conclusions:
Subgroup analyses show different trajectories between institutionalized and outpatients with schizophrenia. The deterioration observed in institutionalized patients may have to do with greater illness severity, heavier medication load, vascular risk factors, and lack of stimulation in institutional settings. Studies documenting the role of these variables would be useful. Cognitive screening tools that assess executive functions would be interesting to study in schizophrenics, as they may reveal more subtle age-related cognitive changes not measured by the MMSE.
Insights
Mini-Mental State Examination (MMSE) scores in schizophrenia patients decline five times faster than in the general population. This decline is significantly more pronounced in institutionalized patients compared to community-dwelling individuals.
Area of Science:
- Neuroscience
- Psychiatry
- Gerontology
Background:
- The Mini-Mental State Examination (MMSE) is a common cognitive screening tool used in schizophrenia research.
- Normative MMSE data for the schizophrenia population are limited.
- Aging effects on cognitive function in schizophrenia require further investigation.
Purpose of the Study:
- To analyze the impact of aging on Mini-Mental State Examination (MMSE) scores in patients with schizophrenia.
- To compare the rate of cognitive decline due to aging between institutionalized and community-dwelling schizophrenia patients.
Main Methods:
- A systematic literature search was conducted using PubMed and PsychInfo with keywords 'schizophrenia' and 'MMSE'.
- Included studies provided MMSE scores and mean age for schizophrenia patients.
- A weighted linear regression analysis was performed, with weights inversely proportional to the variance of the age variable.
Main Results:
- A meta-regression analysis of 56 articles (5,588 patients) revealed that MMSE scores in schizophrenia patients decline by approximately 1 point every four years.
- This rate of decline is five times greater than that observed in the general population.
- Institutionalized patients showed a significant decline in MMSE scores with age (R² = 0.622), while community-dwelling patients exhibited relatively stable scores (R² = 0.037).
Conclusions:
- Significant differences in age-related cognitive trajectories exist between institutionalized and community-dwelling schizophrenia patients.
- Factors such as illness severity, medication, vascular risks, and environmental stimulation may contribute to cognitive decline in institutionalized patients.
- Further research on executive functions and the impact of specific variables is recommended for a comprehensive understanding of cognitive aging in schizophrenia.
More Related Videos
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Schizophrenia

